Keywords: anti-Mi-2 antibody; anti-aminoacyl tRNA synthetase (anti-ARS) antibody; anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody; anti-transcriptional intermediary factor 1-γ (anti-TIF1γ) antibody; clinically amyopathic dermatomyositis; dermatomyositis; idiopathic inflammatory myopathies; myositis-specific autoantibodies; periungual changes; polymyositis.